In reply: We agree that attention to terminology is important, and that claims about potential medical advances are often exaggerated. On the other hand, on the rare occasions when things go really well, we should not hide our light under a bushel.
The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.
- NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW.
Correspondence: rhana@ctc.usyd.edu.au
- 1. Early Breast Cancer Trialists’ Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365: 1687-1717.
- 2. Bonadonna G, Moliterni A, Zambetti M, et al. 30 years’ follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study. BMJ 2005; 330: 217.
- 3. Eliot TS. The journey of the Magi. In: Collected poems 1909–1962. London: Faber and Faber, 1963: 109.
Online responses are no longer available. Please refer to our instructions for authors page for more information.